The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Interventional Oncology Device Market Research Report 2024

Global Interventional Oncology Device Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1606017

No of Pages : 105

Ask Your Query

Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.

Global Interventional Oncology Device market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Interventional Oncology Device market research.

Key manufacturers engaged in the Interventional Oncology Device industry include AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC and Medwaves, Inc., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Interventional Oncology Device were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Interventional Oncology Device market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Interventional Oncology Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List)

  •     AngioDynamics, Inc.
  •     BD
  •     Boston Scientific Corporation
  •     BTG Plc
  •     Eckert & Ziegler BEBIG
  •     HealthTronics, Inc.
  •     IceCure Medical
  •     Medtronic PLC
  •     Medwaves, Inc.
  •     Merit Medical Systems, Inc.
  •     Sanarus Technologies, Inc.
  •     Sirtex Medical Ltd.
  •     Sonacare Medical
  •     Terumo Corporation
  •     Trod Medical
  •     Cook Meidical LLC

Segment by Type

  •     Ablation Devices
  •     Embolization Devices
  •     Supporting Devices
  •     Next Generation Devices

Segment by Application

  •     Hospitals
  •     Specialty Clinics and Ambulatory Surgical Centers
  •     Others (Homecare and Research Institutes)

Consumption by Region

  •     North America (United States, Canada)
  •     Europe (Germany, France, U.K., Italy, Russia)
  •     Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  •     Latin America (Mexico, Brazil, Argentina)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Interventional Oncology Device report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

1 Interventional Oncology Device Market Overview
    1.1 Product Overview and Scope of Interventional Oncology Device
    1.2 Interventional Oncology Device Segment by Type
        1.2.1 Global Interventional Oncology Device Market Value Comparison by Type (2023-2029)
        1.2.2 Ablation Devices
        1.2.3 Embolization Devices
        1.2.4 Supporting Devices
        1.2.5 Next Generation Devices
    1.3 Interventional Oncology Device Segment by Application
        1.3.1 Global Interventional Oncology Device Market Value by Application: (2023-2029)
        1.3.2 Hospitals
        1.3.3 Specialty Clinics and Ambulatory Surgical Centers
        1.3.4 Others (Homecare and Research Institutes)
    1.4 Global Interventional Oncology Device Market Size Estimates and Forecasts
        1.4.1 Global Interventional Oncology Device Revenue 2018-2029
        1.4.2 Global Interventional Oncology Device Sales 2018-2029
        1.4.3 Global Interventional Oncology Device Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Interventional Oncology Device Market Competition by Manufacturers
    2.1 Global Interventional Oncology Device Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Interventional Oncology Device Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Interventional Oncology Device Average Price by Manufacturers (2018-2023)
    2.4 Global Interventional Oncology Device Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Interventional Oncology Device, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Interventional Oncology Device, Product Type & Application
    2.7 Interventional Oncology Device Market Competitive Situation and Trends
        2.7.1 Interventional Oncology Device Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Interventional Oncology Device Players Market Share by Revenue
        2.7.3 Global Interventional Oncology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Interventional Oncology Device Retrospective Market Scenario by Region
    3.1 Global Interventional Oncology Device Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Interventional Oncology Device Global Interventional Oncology Device Sales by Region: 2018-2029
        3.2.1 Global Interventional Oncology Device Sales by Region: 2018-2023
        3.2.2 Global Interventional Oncology Device Sales by Region: 2024-2029
    3.3 Global Interventional Oncology Device Global Interventional Oncology Device Revenue by Region: 2018-2029
        3.3.1 Global Interventional Oncology Device Revenue by Region: 2018-2023
        3.3.2 Global Interventional Oncology Device Revenue by Region: 2024-2029
    3.4 North America Interventional Oncology Device Market Facts & Figures by Country
        3.4.1 North America Interventional Oncology Device Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Interventional Oncology Device Sales by Country (2018-2029)
        3.4.3 North America Interventional Oncology Device Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Interventional Oncology Device Market Facts & Figures by Country
        3.5.1 Europe Interventional Oncology Device Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Interventional Oncology Device Sales by Country (2018-2029)
        3.5.3 Europe Interventional Oncology Device Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Interventional Oncology Device Market Facts & Figures by Country
        3.6.1 Asia Pacific Interventional Oncology Device Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Interventional Oncology Device Sales by Country (2018-2029)
        3.6.3 Asia Pacific Interventional Oncology Device Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Interventional Oncology Device Market Facts & Figures by Country
        3.7.1 Latin America Interventional Oncology Device Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Interventional Oncology Device Sales by Country (2018-2029)
        3.7.3 Latin America Interventional Oncology Device Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Interventional Oncology Device Market Facts & Figures by Country
        3.8.1 Middle East and Africa Interventional Oncology Device Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Interventional Oncology Device Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Interventional Oncology Device Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Interventional Oncology Device Sales by Type (2018-2029)
        4.1.1 Global Interventional Oncology Device Sales by Type (2018-2023)
        4.1.2 Global Interventional Oncology Device Sales by Type (2024-2029)
        4.1.3 Global Interventional Oncology Device Sales Market Share by Type (2018-2029)
    4.2 Global Interventional Oncology Device Revenue by Type (2018-2029)
        4.2.1 Global Interventional Oncology Device Revenue by Type (2018-2023)
        4.2.2 Global Interventional Oncology Device Revenue by Type (2024-2029)
        4.2.3 Global Interventional Oncology Device Revenue Market Share by Type (2018-2029)
    4.3 Global Interventional Oncology Device Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Interventional Oncology Device Sales by Application (2018-2029)
        5.1.1 Global Interventional Oncology Device Sales by Application (2018-2023)
        5.1.2 Global Interventional Oncology Device Sales by Application (2024-2029)
        5.1.3 Global Interventional Oncology Device Sales Market Share by Application (2018-2029)
    5.2 Global Interventional Oncology Device Revenue by Application (2018-2029)
        5.2.1 Global Interventional Oncology Device Revenue by Application (2018-2023)
        5.2.2 Global Interventional Oncology Device Revenue by Application (2024-2029)
        5.2.3 Global Interventional Oncology Device Revenue Market Share by Application (2018-2029)
    5.3 Global Interventional Oncology Device Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 AngioDynamics, Inc.
        6.1.1 AngioDynamics, Inc. Corporation Information
        6.1.2 AngioDynamics, Inc. Description and Business Overview
        6.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 AngioDynamics, Inc. Interventional Oncology Device Product Portfolio
        6.1.5 AngioDynamics, Inc. Recent Developments/Updates
    6.2 BD
        6.2.1 BD Corporation Information
        6.2.2 BD Description and Business Overview
        6.2.3 BD Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 BD Interventional Oncology Device Product Portfolio
        6.2.5 BD Recent Developments/Updates
    6.3 Boston Scientific Corporation
        6.3.1 Boston Scientific Corporation Corporation Information
        6.3.2 Boston Scientific Corporation Description and Business Overview
        6.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Boston Scientific Corporation Interventional Oncology Device Product Portfolio
        6.3.5 Boston Scientific Corporation Recent Developments/Updates
    6.4 BTG Plc
        6.4.1 BTG Plc Corporation Information
        6.4.2 BTG Plc Description and Business Overview
        6.4.3 BTG Plc Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 BTG Plc Interventional Oncology Device Product Portfolio
        6.4.5 BTG Plc Recent Developments/Updates
    6.5 Eckert & Ziegler BEBIG
        6.5.1 Eckert & Ziegler BEBIG Corporation Information
        6.5.2 Eckert & Ziegler BEBIG Description and Business Overview
        6.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolio
        6.5.5 Eckert & Ziegler BEBIG Recent Developments/Updates
    6.6 HealthTronics, Inc.
        6.6.1 HealthTronics, Inc. Corporation Information
        6.6.2 HealthTronics, Inc. Description and Business Overview
        6.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 HealthTronics, Inc. Interventional Oncology Device Product Portfolio
        6.6.5 HealthTronics, Inc. Recent Developments/Updates
    6.7 IceCure Medical
        6.6.1 IceCure Medical Corporation Information
        6.6.2 IceCure Medical Description and Business Overview
        6.6.3 IceCure Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 IceCure Medical Interventional Oncology Device Product Portfolio
        6.7.5 IceCure Medical Recent Developments/Updates
    6.8 Medtronic PLC
        6.8.1 Medtronic PLC Corporation Information
        6.8.2 Medtronic PLC Description and Business Overview
        6.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Medtronic PLC Interventional Oncology Device Product Portfolio
        6.8.5 Medtronic PLC Recent Developments/Updates
    6.9 Medwaves, Inc.
        6.9.1 Medwaves, Inc. Corporation Information
        6.9.2 Medwaves, Inc. Description and Business Overview
        6.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Medwaves, Inc. Interventional Oncology Device Product Portfolio
        6.9.5 Medwaves, Inc. Recent Developments/Updates
    6.10 Merit Medical Systems, Inc.
        6.10.1 Merit Medical Systems, Inc. Corporation Information
        6.10.2 Merit Medical Systems, Inc. Description and Business Overview
        6.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolio
        6.10.5 Merit Medical Systems, Inc. Recent Developments/Updates
    6.11 Sanarus Technologies, Inc.
        6.11.1 Sanarus Technologies, Inc. Corporation Information
        6.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Description and Business Overview
        6.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolio
        6.11.5 Sanarus Technologies, Inc. Recent Developments/Updates
    6.12 Sirtex Medical Ltd.
        6.12.1 Sirtex Medical Ltd. Corporation Information
        6.12.2 Sirtex Medical Ltd. Interventional Oncology Device Description and Business Overview
        6.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Sirtex Medical Ltd. Interventional Oncology Device Product Portfolio
        6.12.5 Sirtex Medical Ltd. Recent Developments/Updates
    6.13 Sonacare Medical
        6.13.1 Sonacare Medical Corporation Information
        6.13.2 Sonacare Medical Interventional Oncology Device Description and Business Overview
        6.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Sonacare Medical Interventional Oncology Device Product Portfolio
        6.13.5 Sonacare Medical Recent Developments/Updates
    6.14 Terumo Corporation
        6.14.1 Terumo Corporation Corporation Information
        6.14.2 Terumo Corporation Interventional Oncology Device Description and Business Overview
        6.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.14.4 Terumo Corporation Interventional Oncology Device Product Portfolio
        6.14.5 Terumo Corporation Recent Developments/Updates
    6.15 Trod Medical
        6.15.1 Trod Medical Corporation Information
        6.15.2 Trod Medical Interventional Oncology Device Description and Business Overview
        6.15.3 Trod Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.15.4 Trod Medical Interventional Oncology Device Product Portfolio
        6.15.5 Trod Medical Recent Developments/Updates
    6.16 Cook Meidical LLC
        6.16.1 Cook Meidical LLC Corporation Information
        6.16.2 Cook Meidical LLC Interventional Oncology Device Description and Business Overview
        6.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue and Gross Margin (2018-2023)
        6.16.4 Cook Meidical LLC Interventional Oncology Device Product Portfolio
        6.16.5 Cook Meidical LLC Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Interventional Oncology Device Industry Chain Analysis
    7.2 Interventional Oncology Device Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Interventional Oncology Device Production Mode & Process
    7.4 Interventional Oncology Device Sales and Marketing
        7.4.1 Interventional Oncology Device Sales Channels
        7.4.2 Interventional Oncology Device Distributors
    7.5 Interventional Oncology Device Customers

 8 Interventional Oncology Device Market Dynamics
    8.1 Interventional Oncology Device Industry Trends
    8.2 Interventional Oncology Device Market Drivers
    8.3 Interventional Oncology Device Market Challenges
    8.4 Interventional Oncology Device Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock